8.40% -0.57

Atara Biotherapeutics Inc (ATRA)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ATRA? Forum Prognose

Finanzdaten der Atara Biotherapeutics Inc-Aktie (ATRA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	80.35% 3.453	17.57	98.15	32.75	40.19
Operating Expenses	51.13% 7.027	14.38	59.35	44.96	61.95
Interest Income/Expense	6.48% 0.909	0.972	1.017	1.017	1.183
Benefits Costs and Expenses	49.11% 7.728	15.19	60.14	45.47	62.12
Costs And Expenses	51.13% 7.027	14.38	59.35	44.96	61.95
Depreciation and Amortization	84.75% 0.036	0.236	1.795	1.10	1.23
Operating Income/Loss	211.79% -3.574	3.197	38.80	-12.20	-21.76
Income/Loss From Continuing Operations Before Tax	278.87% -4.275	2.39	38.01	-12.71	-21.93
Income Tax Expense/Benefit	833.33% 0.028	0.003	-	-0.019	-0.017
Income/Loss From Continuing Operations After Tax	280.27% -4.303	2.387	38.01	-12.69	-21.91
Net Income/Loss	280.27% -4.303	2.387	38.01	-12.69	-21.91
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	11.21% 13.56	12.20	10.76	1.074	7.466
Diluted Average Shares	10.19% 13.56	12.31	10.85	1.074	7.466
Basic Earnings Per Share	260.00% -0.32	0.20	3.53	-0.07	-2.93
Diluted Earnings Per Share	268.42% -0.32	0.19	3.50	-0.07	-2.93
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.87

0.18%

ROIV

$28.99

1.33%

MRNA

$54.07

1.61%

BNTX

$90.20

0.16%

INSM

$139.44

0.28%

ONC

$288.30

0.99%